References
- YooJHSuhBParkTSAnalysis of fluorescence in situ hybridization, mtDNA quantification, and mtDNA sequence for the detection of early bladder cancerCancer Genet and Cytogenet2010198210711720362225
- TomeraKMNMP22 (R) BladderChek (R) Test: Point-of-care technology with life and money-saving potentialExpert Rev Mol Diagn20044678379415525221
- SylvesterRJNatural history, recurrence, and progression in superficial bladder cancerScientific World Journal200662617262517619739
- LuoJHHuaWFRaoHLOverexpression of EIF-5A2 predicts tumor recurrence and progression in pTa/pT1 urothelial carcinoma of the bladderCancer Sci2009100589690219298601
- SylvesterRJvan der MeijdenAPMOosterlinckWPredicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trialsEur Urol200649346647716442208
- WangWShaoRPWuQPTargeting gelatinases with a near-infrared fluorescent cyclic His-Try-Gly-Phe peptideMol Imaging Biol200911642443319424760
- LeeSMLeeEJHongHYTargeting bladder tumor cells in vivo and in the urine with a peptide identified by phage displayMol Cancer Res200751111917259343
- XuCLZengQSHouJGUtility of a modality combining FISH and cytology in upper tract urothelial carcinoma detection in voided urine samples of Chinese patientsUrol201177363664121256577
- SavicSBubendorfLFluorescence in situ hybridization: A new diagnostic dimension in cytologyPathologe200728538439217661041
- SokolovaIAHallingKCJenkinsRBThe development of a multitarget, multicolor fluorescence in situ hybridization assay for the detection of urothelial carcinoma in urineJ Mol Diagn20002311612311229514
- van RhijnBWGvan der PoelHGvan der KwastTHUrine markers for bladder cancer surveillance: a systematic reviewEur Urol200547673674815925067
- AkkadTBrunnerAPallweinLFluorescence in situ hybridization for detecting upper urinary tract tumors: A preliminary reportUrol200770475375717991550
- MowattGZhuSKilonzoMSystematic review of the clinical effectiveness and cost-effectiveness of photodynamic diagnosis and urine biomarkers (FISH, ImmunoCyt, NMP22) and cytology for the detection and follow-up of bladder cancerHealth Technol Assess20101441356
- ShariatSFLotanYVickersAStatistical consideration for clinical biomarker research in bladder cancerUrol Oncol201028438940020610277
- LotanYShariatSFSchmitz-DragerBJConsiderations on implementing diagnostic markers into clinical decision making in bladder cancerUrol Oncol201028444144820610281
- LaakkonenPZhangLLRuoslahtiEPeptide targeting of tumor lymph vesselsAnn N Y Acad Sci20081131374318519957
- RaitanenMPKaasinenELukkarinenOAnalysis of false-positive BTA stat test results in patients followed up for bladder cancerUrol200157468068411306380
- InoueTNasuYTsushimaTMiyajiYMurakamiTKumonHChromosomal numerical aberrations of exfoliated cells in the urine detected by fluorescence in situ hybridization: Clinical implication for the detection of bladder cancerUrol Res2000281576110732697
- YangZhaoYangXiao-fengHaoX-qPeptides CSNRDARRC affinity and binding sites study of bladder cancer markerJ Contemp Urol201132105107
- Marin-AguileraMMengualLRibalMJUtility of a multiprobe fluorescence in situ hybridization assay in the detection of superficial urothelial bladder cancerCancer Genet Cytogenet2007173213113517321328
- SongM-JLeeH-MKimS-HClinical usefulness of fluorescence in situ hybridization for diagnosis and surveillance of bladder cancerCancer Genet Cytogenet152010198214415020362229
- GuarnizoEPavlovichCPSeibaMCarlsonDLVaughanEDSosaREUreteroscopic biopsy of upper tract urothelial carcinoma: Improved diagnostic accuracy and histopathological considerations using a multibiopsy approachJ Urol20001631525510604312
- Marin-AguileraMMenqualLRibalMJUtility of fluorescence in situ hybridization as a non-invasive technique in the diagnosis of upper urinary tract urothelial carcinomaEur Urol200751240941517010508
- HallingKCKippBRBladder cancer detection using FISH (UroVysion assay)Adv Anat Pathol200815527928618724101